about
Crystal Structure of the Geobacillus stearothermophilus Carboxylesterase Est55 and Its Activation of Prodrug CPT-11Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control.Colorectal cancer targeted Irinotecan-Assam Bora rice starch based microspheres: a mechanistic, pharmacokinetic and biochemical investigation.Contributions made by CDC25 phosphatases to proliferation of intestinal epithelial stem and progenitor cellsDownregulation of cystine transporter xc by irinotecan in human head and neck cancer FaDu xenografts.Comet assay measures of DNA damage as biomarkers of irinotecan response in colorectal cancer in vitro and in vivoCharacterization of [(99m)Tc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis.The p53 isoform delta133p53ß regulates cancer cell apoptosis in a RhoB-dependent manner.The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients.ISG15 as a novel tumor biomarker for drug sensitivity.Targeted therapy of cancer: new roles for pathologists in colorectal cancer.Experience with irinotecan for the treatment of malignant gliomaCell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development.Platinum-based chemotherapy: gastrointestinal immunomodulation and enteric nervous system toxicity.Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer.Synergistic Effects of Simvastatin and Irinotecan against Colon Cancer Cells with or without Irinotecan Resistance.Imatinib and its combination with 2,5-dimethyl-celecoxibinduces apoptosis of human HT-29 colorectal cancer cells.Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells: tumor-tropic potential and inhibition of ovarian cancer cell growth.Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells.Cytomegalovirus colitis after systemic chemotherapy in a patient with recurrent colon cancer: a case report.Intercostal artery pseudoaneurysm formation after irinotecan transarterial chemoembolization of a spinal metastasis from colorectal cancer.Irinotecan-induced central nervous system toxicity. Report on two cases and review of the literature.PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan.Topoisomerase-1 gene copy aberrations are frequent in patients with breast cancer.Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant gene associated with Angelman syndromeSequential administration of camptothecin sensitizes human colon cancer HCT116 cells to paclitaxel via p21Cip1/WAF1Stem cell enriched-epithelial spheroid cultures for rapidly assaying small intestinal radioprotectors and radiosensitizers in vitro
P2860
Q27641256-50DC38CA-FAAF-4C0F-80AA-F908B7C149F4Q33390327-AC41877B-768D-420F-8773-41EB0795D5DDQ33403536-DFB8FC0C-EF86-4E4F-BF87-46CF3467FEE9Q33808811-7C4D673E-A743-4F5F-A7E5-C96F0CDD91A6Q34038268-1217B237-977A-4622-8FE1-44221DA658F2Q36051757-6D6E2B54-4AA9-4027-95B4-F148B5777242Q36269742-B7195328-E57C-4FC6-B29A-43701E1DFF87Q36284222-B489C2E3-8871-47B4-9F05-763EF28B6ED1Q36895084-788DE931-910A-4113-936F-84654B6BAE59Q36922901-290738E2-11E7-444F-85A4-00A833272F07Q37147762-5FDC098F-2672-4EB8-B1EA-DE4577D85C54Q37265907-1BA0B3DF-02E8-42CC-A7FB-66087454A9FCQ38088759-49AA1CF5-D2E3-4367-A8FF-9B624BBE4492Q38287054-54F688FE-2FE3-43BF-B214-FCB923E6397EQ38357424-C3DCED91-FA92-4583-9FB5-2142702962E3Q38540360-E4B1E2DB-8580-425A-8BDA-01D269B68667Q38714062-44240BB9-0EA6-4C0F-8BF6-A8E9AD79EBA1Q39137011-1BF40CEB-2E9C-4A92-9091-3B845A4BD90BQ39472164-017A1E57-107B-4773-85E7-89CFC834B764Q42149135-94D45596-98C7-4253-A180-DA2FAAD3BE44Q42474174-6D9269FB-1C2B-4747-A5A2-4719BEC4C795Q46960024-BCD380B3-FBEE-4AB7-9B9E-5F3E3801A568Q50587758-9F8CE341-13F6-4164-92D5-DD9C6D826D22Q53552603-DDEF292C-159E-45FB-923D-754FEB6F0796Q57168803-A0BEAAD9-0F1C-45E3-AC01-3206ABA3C5B9Q58308570-EE873345-8584-41EE-B81D-AE4AB7976AC9Q58603126-38B932E8-A965-49B5-BF54-D4BEC388ED0A
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Irinotecan in the treatment of colorectal cancer.
@ast
Irinotecan in the treatment of colorectal cancer.
@en
type
label
Irinotecan in the treatment of colorectal cancer.
@ast
Irinotecan in the treatment of colorectal cancer.
@en
prefLabel
Irinotecan in the treatment of colorectal cancer.
@ast
Irinotecan in the treatment of colorectal cancer.
@en
P1476
Irinotecan in the treatment of colorectal cancer.
@en
P2093
Edith P Mitchell
Paulo M Hoff
P304
P356
10.1016/J.CTRV.2006.07.001
P577
2006-09-07T00:00:00Z